GUANG.BAIY.PHAR.HO.H YC 1GUANG.BAIY.PHAR.HO.H YC 1GUANG.BAIY.PHAR.HO.H YC 1

GUANG.BAIY.PHAR.HO.H YC 1

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.96 B‬EUR
0.21EUR
‪382.14 M‬EUR
‪10.07 B‬EUR
‪219.90 M‬
Beta (1Y)
0.73
Employees (FY)
‪28.14 K‬
Change (1Y)
+90 +0.32%
Revenue / Employee (1Y)
‪357.77 K‬EUR
Net income / Employee (1Y)
‪13.58 K‬EUR

About GUANGZHOU BAIYUNSHAN PHARMACEUTICAL


CEO
Hong Li
Headquarters
Guangzhou
Founded
1997
ISIN
CNE100000387
FIGI
BBG000BGYYR0
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as GU5.

Frequently Asked Questions


The current price of GU5 is 1.96 EUR — it has increased by 0.51% in the past 24 hours. Watch GUANG.BAIY.PHAR.HO.H YC 1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GUANG.BAIY.PHAR.HO.H YC 1 stocks are traded under the ticker GU5.
GU5 stock has risen by 1.55% compared to the previous week, the month change is a 1.55% rise, over the last year GUANG.BAIY.PHAR.HO.H YC 1 has showed a −18.33% decrease.
We've gathered analysts' opinions on GUANG.BAIY.PHAR.HO.H YC 1 future price: according to them, GU5 price has a max estimate of 2.64 EUR and a min estimate of 1.48 EUR. Watch GU5 chart and read a more detailed GUANG.BAIY.PHAR.HO.H YC 1 stock forecast: see what analysts think of GUANG.BAIY.PHAR.HO.H YC 1 and suggest that you do with its stocks.
GU5 reached its all-time high on May 2, 2019 with the price of 4.58 EUR, and its all-time low was 1.20 EUR and was reached on Dec 3, 2012. View more price dynamics on GU5 chart.
See other stocks reaching their highest and lowest prices.
GU5 stock is 0.51% volatile and has beta coefficient of 0.73. Track GUANG.BAIY.PHAR.HO.H YC 1 stock price on the chart and check out the list of the most volatile stocks — is GUANG.BAIY.PHAR.HO.H YC 1 there?
Today GUANG.BAIY.PHAR.HO.H YC 1 has the market capitalization of ‪3.23 B‬, it has increased by 1.19% over the last week.
Yes, you can track GUANG.BAIY.PHAR.HO.H YC 1 financials in yearly and quarterly reports right on TradingView.
GUANG.BAIY.PHAR.HO.H YC 1 is going to release the next earnings report on Aug 13, 2025. Keep track of upcoming events with our Earnings Calendar.
GU5 earnings for the last quarter are 0.14 EUR per share, whereas the estimation was 0.07 EUR resulting in a 103.64% surprise. The estimated earnings for the next quarter are 0.05 EUR per share. See more details about GUANG.BAIY.PHAR.HO.H YC 1 earnings.
GU5 net income for the last quarter is ‪231.28 M‬ EUR, while the quarter before that showed ‪−43.48 M‬ EUR of net income which accounts for 631.87% change. Track more GUANG.BAIY.PHAR.HO.H YC 1 financial stats to get the full picture.
GUANG.BAIY.PHAR.HO.H YC 1 dividend yield was 4.83% in 2024, and payout ratio reached 46.45%. The year before the numbers were 3.78% and 29.85% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 14, 2025, the company has ‪28.14 K‬ employees. See our rating of the largest employees — is GUANG.BAIY.PHAR.HO.H YC 1 on this list?
Like other stocks, GU5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUANG.BAIY.PHAR.HO.H YC 1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUANG.BAIY.PHAR.HO.H YC 1 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUANG.BAIY.PHAR.HO.H YC 1 stock shows the sell signal. See more of GUANG.BAIY.PHAR.HO.H YC 1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.